Horizon Europe Cluster Salud

Deialdiak
22/06/2021
Horizon Europe Cluster Salud
22/06/2021
21/09/2021
Comisión Europea
Proiektuak
Nazioartekoa
22/06/2021
Añadir al calendario 2021-06-22 02:00:00 2021-09-21 02:00:00 Horizon Europe Cluster Salud Convocatoria englobada dentro del Clúster 1 “Salud” de Horizonte Europa para la financiación de proyectos colaborativos, acciones complementarias y de coordinación a través de diferentes topics o temáticas.   El Clúster 1 se divide en convocatorias de una o dos fases. A continuación el listado de los topics de una fase cuyo plazo de envío de solicitudes cierra el 21 de septiembre de 2021:   Destination 1. Staying healthy in a rapidly changing society HORIZON-HLTH-2021-STAYHLTH-01-02 (RIA): Towards a molecular and neurobiological understanding of mental health and mental illness for the benefit of citizens and patients. HORIZON-HLTH-2021-STAYHLTH-01-03 (CSA): Healthy citizens 2.0 - Supporting digital empowerment and health literacy. HORIZON-HLTH-2021-STAYHLTH-01-04 (CSA): A roadmap for personalised prevention. HORIZON-HLTH-2021-STAYHLTH-01-05 (CSA):Mobilising the network of National Contact Points in the Health Cluster.   Destination 2. Living & working in a health-promoting environment HORIZON-HLTH-2021-ENVHLTH-02-01 (RIA): Exposure to electromagnetic fields (EMF) and health. HORIZON-HLTH-2021-ENVHLTH-02-02 (RIA): Indoor air quality and health. HORIZON-HLTH-2021-ENVHLTH-02-03 (RIA): Health impacts of climate change, costs and benefits of action and inaction. HORIZON-HLTH-2021-ENVHLTH-03-01 (COFUND): European Partnership for the Assessment of Risks from Chemicals (PARC).   Destination 3. Tackling diseases & reducing disease burden HORIZON-HLTH-2021-DISEASE-04-01 (RIA): Improved supportive, palliative, survivorship and end-of-life care of cancer patients. HORIZON-HLTH-2021-DISEASE-04-02 (RIA): Building a European innovation platform for the repurposing of Medicinal products HORIZON-HLTH-2021-DISEASE-04-03 (RIA): Innovative approaches to enhance poverty related diseases research in sub-Saharan Africa. HORIZON-HLTH-2021-DISEASE-04-04 (RIA): Clinical validation of artificial intelligence (AI) solutions for treatment and care. HORIZON-HLTH-2021-DISEASE-04-05 (CSA): A roadmap towards the creation of the European One Health antimicrobial resistance partnership (OH AMR). HORIZON-HLTH-2021-DISEASE-04-07 (RIA-CSA): Personalised Medicine and infectious diseases: understanding the individual host response to viruses (e.g., SARS-CoV-2). HORIZON-HLTH-2021-DISEASE-04-06 (CSA): Building a European Research and Innovation Partnership for Pandemic Preparedness.   Destination 4. Ensuring access to innovative, sustainable & high-quality health care HORIZON-HLTH-2021-CARE-05-01 (RIA): Enhancing quality of care and patient safety. HORIZON-HLTH-2021-CARE-05-02 (RIA): Data-driven decision-support tools for better health and care delivery and policy-making with a focus on cancer. HORIZON-HLTH-2021-CARE-05-04 (CSA): Health care innovation procurement network   Destination 5. Unlocking the full potential of new tools, technologies and digital solutions for a healthy society HORIZON-HLTH-2021-TOOL-06-01 (IA): Smart Medical devices and their surgical implantation for use in resource-constrained settings. HORIZON-HLTH-2021-TOOL-06-02 (RIA): Next generation advanced therapies to treat highly prevalent and high burden diseases with unmet needs. HORIZON-HLTH-2021-TOOL-06-03 (RIA): Innovative tools for use and re-use of health data(in particular electronic health records and/or patient registries).   Destination 6.Maintaining an innovative, sustainable & globally competitive health industry HORIZON-HLTH-2021-IND-07-01 (RIA): Green pharmaceuticals. HORIZON-HLTH-2021-IND-07-02 (CSA): Development procurement and responsible management of new antimicrobials. HORIZON-HLTH-2021-IND-07-03 (CSA): Promoting a trusted MHealth label in Europe: uptake of Technical specifications for quality and reliability of health and wellness apps. Location Navarrabiomed info@navarrabiomed Europe/Madrid public

Convocatoria englobada dentro del Clúster 1 “Salud” de Horizonte Europa para la financiación de proyectos colaborativos, acciones complementarias y de coordinación a través de diferentes topics o temáticas.  

El Clúster 1 se divide en convocatorias de una o dos fases. A continuación el listado de los topics de una fase cuyo plazo de envío de solicitudes cierra el 21 de septiembre de 2021:

 

Destination 1. Staying healthy in a rapidly changing society

  • HORIZON-HLTH-2021-STAYHLTH-01-02 (RIA): Towards a molecular and neurobiological understanding of mental health and mental illness for the benefit of citizens and patients.
  • HORIZON-HLTH-2021-STAYHLTH-01-03 (CSA)Healthy citizens 2.0 - Supporting digital empowerment and health literacy.
  • HORIZON-HLTH-2021-STAYHLTH-01-04 (CSA): A roadmap for personalised prevention.
  • HORIZON-HLTH-2021-STAYHLTH-01-05 (CSA):Mobilising the network of National Contact Points in the Health Cluster.

 

Destination 2. Living & working in a health-promoting environment

  • HORIZON-HLTH-2021-ENVHLTH-02-01 (RIA): Exposure to electromagnetic fields (EMF) and health.
  • HORIZON-HLTH-2021-ENVHLTH-02-02 (RIA): Indoor air quality and health.
  • HORIZON-HLTH-2021-ENVHLTH-02-03 (RIA): Health impacts of climate change, costs and benefits of action and inaction.
  • HORIZON-HLTH-2021-ENVHLTH-03-01 (COFUND): European Partnership for the Assessment of Risks from Chemicals (PARC).

 

Destination 3. Tackling diseases & reducing disease burden

  • HORIZON-HLTH-2021-DISEASE-04-01 (RIA): Improved supportive, palliative, survivorship and end-of-life care of cancer patients.
  • HORIZON-HLTH-2021-DISEASE-04-02 (RIA): Building a European innovation platform for the repurposing of Medicinal products
  • HORIZON-HLTH-2021-DISEASE-04-03 (RIA): Innovative approaches to enhance poverty related diseases research in sub-Saharan Africa.
  • HORIZON-HLTH-2021-DISEASE-04-04 (RIA): Clinical validation of artificial intelligence (AI) solutions for treatment and care.
  • HORIZON-HLTH-2021-DISEASE-04-05 (CSA): A roadmap towards the creation of the European One Health antimicrobial resistance partnership (OH AMR).
  • HORIZON-HLTH-2021-DISEASE-04-07 (RIA-CSA): Personalised Medicine and infectious diseases: understanding the individual host response to viruses (e.g., SARS-CoV-2).
  • HORIZON-HLTH-2021-DISEASE-04-06 (CSA)Building a European Research and Innovation Partnership for Pandemic Preparedness.

 

Destination 4. Ensuring access to innovative, sustainable & high-quality health care

  • HORIZON-HLTH-2021-CARE-05-01 (RIA)Enhancing quality of care and patient safety.
  • HORIZON-HLTH-2021-CARE-05-02 (RIA)Data-driven decision-support tools for better health and care delivery and policy-making with a focus on cancer.
  • HORIZON-HLTH-2021-CARE-05-04 (CSA): Health care innovation procurement network

 

Destination 5. Unlocking the full potential of new tools, technologies and digital solutions for a healthy society

  • HORIZON-HLTH-2021-TOOL-06-01 (IA): Smart Medical devices and their surgical implantation for use in resource-constrained settings.
  • HORIZON-HLTH-2021-TOOL-06-02 (RIA): Next generation advanced therapies to treat highly prevalent and high burden diseases with unmet needs.
  • HORIZON-HLTH-2021-TOOL-06-03 (RIA): Innovative tools for use and re-use of health data(in particular electronic health records and/or patient registries).

 

Destination 6.Maintaining an innovative, sustainable & globally competitive health industry

  • HORIZON-HLTH-2021-IND-07-01 (RIA): Green pharmaceuticals.
  • HORIZON-HLTH-2021-IND-07-02 (CSA): Development procurement and responsible management of new antimicrobials.
  • HORIZON-HLTH-2021-IND-07-03 (CSA): Promoting a trusted MHealth label in Europe: uptake of Technical specifications for quality and reliability of health and wellness apps.
  • Para las Acciones de Investigación e Innovación (RIA) será necesaria la formación de consorcios transnacionales constituido por, al menos, una entidad legalmente establecida en un estado Miembro de la UE y dos entidades de países miembros o asociados.
  • Para las Acciones de Innovación (IA) será necesaria la formación de consorcios transnacionales constituido por, al menos, una entidad legalmente establecida en un estado Miembro de la UE y dos entidades de países miembros o asociados.

Las propuestas se presentan electrónicamente a través del Portal del Participante.

Las propuestas tienen 2 partes:

  • Parte A: Formularios online a cumplimentar con los datos básicos de la propuesta, incluyendo un resumen, y con la información administrativa de la/s entidad/es solicitante/s.
  • Parte B: Memoria científica. La plantilla en formato word se descarga del Portal del Participante una vez registremos la propuesta. Como novedad con respecto a Horizonte 2020, se reduce del número de páginas para la memoria científica: 45 páginas en Acciones de Investigación e Innovación (RIA) y Acciones de Innovación (IA); 30 páginas en Acciones de Coordinación (CSA).

Desde la sección “Start Submission” del topic podremos iniciar el registro de nuestra propuesta (en el resumen inicial podrá encontrar el enlace correspondiente a cada uno de los topics).

 

Los criterios de evaluación se establecerán para cada convocatoria, aunque de forma general se evaluará:

  • La excelencia, así como el nivel de innovación con relación a los objetivos del topic.
  • Impacto, mediante el desarrollo, difusión y utilización de los resultados del proyecto.
  • La calidad y eficiencia de la implementación del proyecto, calidad del consorcio, competencias y complementariedades, adecuación de los recursos utilizados, calidad de la gestión de conocimiento y resultados.